Scientific Publications

Drug Resistance and Viral Tropism in HIV-1 Subtype C-Infected Patients in KwaZulu-Natal, South Africa: Implications for Future Treatment Options
Singh A, Sunpath H, Green TN, Padayachi N, Hiramen K, Lie Y, Anton ED, Murphy R, Reeves JD, Kuritzkes DR, Ndungʼu T
J Acquir Immune Defic Syndr. 2011 58(3):233-240

Read publication

Antiretroviral prophylaxis: a defining moment in HIV control.
Abdool Karim SS, Abdool Karim Q.
Lancet 2011; 8(9809):e23-e25.

Read publication

Microbicides: New Hope for HIV Prevention
Abdool Karim, SS
UN Chronicle, 2011 XLVIII (1):14-15

Read publication

An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa
Mosam, A., Uldrick, T.S., Shaik, F., Carrara, H., Aboobaker, J., Coovadia, H.
International Journal of STD and AIDS 2011; 22(11): 671-673.

Read publication

Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 representing the initial autologous neutralizing antibody response in an HIV-1 subtype C infected individual
Gray ES, Moody MA, Wibmer CK, Chen X, Marshall D, Amos J, Moore PL, Foulger A, Yu J, Lambson B, Abdool Karim SS, Whitesides J, Tomaras GD, Haynes BF, Morris L, and Liao H
Journal of Virology 2011: 85(15): 7719-7729

Read publication

Justifying Research Risks in a Clinical Trial for Treatment of Multidrug-Resistant Tuberculosis
Heilig CM, Chia D, El-Sadr WM, Hirsch-Moverman Y, MacKenzie WR, Saukkonen J, Villarino M, Padayatchi N
IRB: Ethics and Human Research 2011; 33(4):10-17.

Read publication

Unusual presentation of extrapulmonary tuberculosis: a case report on mammary tuberculosis.
Khan M, Naidoo K.
Southern African Journal of HIV Medicine 2011; 12(2):45-46.

Read publication

Drug Resistance and Viral Tropism in HIV-1 Subtype C-Infected Patients in KwaZulu-Natal, South Africa.
Singh A, Sunpath H, Green TN, Padayachi N, Hiramen K, Lie Y, Anton ED, Murphy R, Reeves JD, Kuritzkes DR, Ndungʼu T. Drug Resistance and Viral Tropism in HIV-1 Subtype C-Infected Patients in KwaZulu-Natal, South Africa:Implications for Future Treatment Options.
J Acquir Immune Defic Syndr 2011; 58(3):233-240.

Read publication

Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa.
Williams BG, Abdool Karim SS, Gouws E, Abdool Karim Q.
JAIDS 2011 Oct 1;58(2):207-10.

Read publication

Integration of Antiretroviral Therapy with Tuberculosis Treatment.
Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, Gengiah T, Gengiah S, Naidoo A, Jithoo N, Nair G, El-Sadr WM, Friedland G, Abdool Karim Q.
New England Journal of Medicine 2011; 365(16):1492-1501

Read publication

Contraceptive Choices, Pregnancy Rates, and Outcomes in a Microbicide Trial.
Sibeko S, Baxter C, Yende N, Abdool Karim Q, Abdool Karim SS, on behalf of the Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 Trial Group.
Obstetrics and Gynecology 2011; 118(4): 895–904.

Read publication

Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting.
Morris L, Chen X, Alam M, Tomaras G, Zhang R, Marshall D, Chen B, Parks B, Foulger A, Jaeger F, Donathan M, Bilska M, Gray ES, Abdool Karim SS, Kepler TB, Whitesides J, Montefiori D, Moody AM; Liao H-X, Haynes BF.
PLoS One 2011; 6(9): e23532.

Read publication

HIV-Associated Tuberculosis.
Naidoo K, Naidoo K, Padayatchi N, Abdool Karim Q.
Clinical and Developmental Immunology; Volume 2011:art. no. 585919 doi:10.1155/2011/585919

Read publication

Association of Polymorphisms in the LEDGF/p75 Gene (PSIP1) with Susceptibility to HIV-1 Infection and Disease Progression.
Madlala P, Gijsbers R, Christ F, Hombrouck A, Werner L, Mlisana K, An P, Abdool Karim SS, Winkler CA, Debyser Z, Ndungʼu T.
AIDS 2011; 25(14):1711-9.

Read publication

HIV prevalence among high school learners - Opportunities for schools-based HIV testing programmes and sexual reproductive health services.
Kharsany AMB, Mlotshwa M, Frohlich JA, Yende Zuma N, Samsunder N, Abdool Karim SS, Abdool Karim Q.
BMC Public Health 2012; 12(1):231.

Read publication

HIV prevention transformed: the new prevention research agenda.
Padian NS, McCoy SI, Abdool Karim S, Hasen N, Kim J, Bartos M, Katabira E, Bertozzi S, Schwartländer B, Cohen MS.
Lancet 2011; 378: 269–278.

Read publication

Research Risks in a Clinical Trial for Treatment of Multidrug-Resistant Tuberculosis.
Heilig CM, Chia D, El-Sadr WM, Hirsch-Moverman Y, MacKenzie WR, Padayatchi N, Saukkonen J, Villarino M. Justifying IRB: Ethics & Human Research 33, no. 4 (2011):10-17

Read publication

Virological and Immunological Factors Associated with HIV-1 Differential Disease Progression in HLA-B*58:01 Positive Individuals.
Chopera DR, Mlotshwa M, Woodman Z, Mlisana K, de Assis Rosa D, Martin DP, Abdool Karim S, Gray CM, Williamson C; the CAPRISA 002 Study Team.
Journal of Virology 2011; 85(14):7070-7080.

Read publication

Initiating antiretrovirals during tuberculosis treatment: a drug safety review
Gengiah TN, Gray AL, Naidoo K, Abdool Karim Q.
Expert Opinion on Drug Safety 2011; 10(4): 559–574

Read publication

Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.
Gray GE, Allen M, Moodie Z, Churchyard G, Bekker L-G, Nchabeleng M, Mlisana K, Metch B, de Bruyn G, Latka MH, Roux S, Mathebula M, Naicker N, Ducar C, Carter DK, Puren A, Eaton N, McElrath JM, Robertson M, Corey L, Kublin JG, on behalf of the HVTN 503/Phambili study team.
Lancet Infectious Diseases 2011; 11(7): 507-515.

Read publication

Safety and Effectiveness of BufferGel and 0.5% PRO2000 Gel for the Prevention of HIV Infection in high-risk Women.
Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, Mâsse B, Hillier SL, Soto-Torres L on behalf of the HPTN 035 Study Team.
AIDS 2011; 25(7):957-966.

Read publication

Stigma impedes AIDS prevention.
Abdool Karim SS.
Nature 2011; 474: 29-31.

Read publication

TB/HIV: An Orphan Disease?
Brust JCM, O'Donnell MR, Metcalfe JZ.
American Journal of Respiratory and Critical Care Medicine 2011; 183(11):1441-2.

Read publication

Influence of Variations in CCL3L1 and CCR5 on Tuberculosis in a Northwestern Colombian Population.
Mamtani M, Mummidi S, Ramsuran V, Pham M-H, Maldonado R, Begum K, Valera MS, Sanchez R, Castiblanco J, Kulkarni H, Ndung'u T, He W, Anaya JM, Ahuja SK.
Journal of Infectious Diseases 2011; 203(11):1590-4.

Read publication

Public health measures to control tuberculosis in low-income countries: Ethics and human rights considerations.
Kraemer JD, Cabrera OA, Singh JA , Depp TB, Gostin LO.
International Journal of Tuberculosis and Lung Disease 2011; 15(SUPPL 2): S19-S24.

Read publication

Isolation of a monoclonal antibody targeting the alpha-2 helix of gp120 representing the initial autologous neutralizing antibody response in an HIV-1 subtype C infected individual.
Gray ES, Moody MA, Wibmer CK, Chen X, Marshall D, Amos J, Moore PL, Foulger A, Yu J, Lambson B, Abdool Karim SS, Whitesides J, Tomaras GD, Haynes BF, Morris L, Liao H.
Journal of Virology 2011: 85(15): 7719-29.

Read publication

Duffy-Null-Associated Low Neutrophil Counts Influence HIV-1 Susceptibility in High-Risk South African Black Women.
Ramsuran V, Kulkarni H; He W; Mlisana K, Wright E, Werner L, Castiblanco-Quinche J, Dhanda R, Le T, Dolan M, Guan W, Weiss R, Clark R, Abdool Karim S, Ahuja SK, Ndung'u T.
Clinical Infectious Diseases 2011; 52(10):1248–1256.

Read publication

Potent and broad neutralization of HIV-1 subtype C 1 viruses by plasma 2 antibodies targeting a quaternary epitope including residues in the V2 loop.
Moore PL, Gray ES, Sheward D, Madiga M, Ranchobe N, Lai Z, Honnen WJ, Nonyane M, Tumba N, Hermanus T, Sibeko S, Mlisana K, Abdool Karim SS, Williamson C, Pinter A, Morris L, and the CAPRISA 002 study.
Journal of Virology 2011; 85(7):3128-3141.

Read publication

Strengthening biostatistics resources in sub-Saharan Africa: Research collaborations through U.S. Partnerships.
Gezmu M, DeGruttola V, Dixon D, Essex M, Halloran E, Hogan J, Grobler A, Kim S, McDermott J, McKaiga R, Neaton JD.
Statistics in Medicine 2011; 30(7):695-708.

Read publication

Case 15-2011 — A 19-Year-Old South African Woman with Headache, Fatigue, and Vaginal Discharge.
Venter FWD, Ndung'u T, Abdool Karim Q.
New England Journal of Medicine 2011; 364(20):1956-1964.

Read publication

Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa.
O'Donnell MR, Zelnick J, Werner L, Master I, Loveday M, Horsburgh CR, Padayatchi N.
Emerging Infectious Diseases 2011; 17(10):1942-5.

Read publication

Asking the right questions: Developing evidence-based strategies for treating HIV in women and children.
Abdool Karim, Q., Banegura A, Cahn P, Christie CD, Dintruff R, Distel M, Hankins C, Hellmann N, Katabira E, Lehrman S, Montaner J, Purdon S, Rooney JF, Wood R, Heidari S.
BMC Public Health 2011; 11: 388. DOI: 10.1186/1471-2458-11-388.

Read publication

A phase iia randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade RAD5 HIV-1 vaccine boost in healthy adults (HVTN204).
Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, Dolin R, Blattner W, Kalichman A, Figueroa JP, Pape J, Schechter M, Defawe O, De Rosa SC, Montefiori DC, Nabel GJ, Corey L, Keefer MC; NIAID HIV Vaccine Trials Network.
PLoS One 2011; 6 (8):e21225.

Read publication

Counsellor-delivered HIV risk reduction intervention addresses safer sex barriers of people living with HIV in KwaZulu-Natal, South Africa.
Cornman, D.H., Christie, S., Shepherd, L.M., MacDonald, S., Amico, K.R., Smith, L.R., Shuper, P.A., Adelaja, A.a, Mahlase, G., Fröhlich, J.A., Pillay, S., Lalloo, U.G., Fisher, W.A., Fisher, J.D.
Psychology and Health 2011; 26(12):1623-1641.

Read publication

Experience in international clinical research: the HIV Prevention Trials Network (HPTN).
Sista ND, Abdool Karim Q, Hinson S, Donnell D, Eshleman SH, and Vermund SH.
Clinical Investigation 2011; 1(12):1609-1618.

Read publication

Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals.
Tomaras GD, Binley JM, Gray ES, Crooks ET, Osawa K, Moore PL, Tumba N, Tong T, Shen X, Yates NL, Decker J, Wibmer CK, Gao F, Alam SM, Easterbrook P, Abdool Karim S, Kamanga G, Crump JA, Cohen M, Shaw GM, Mascola JR, Haynes BF, Montefiori DC, Morris L.
Journal of Virology 2011; 85(21):11502-19.

Read publication

The ethics of national tuberculosis programmes in low-income countries not rolling out Xpert ® MTB/RIF.
Singh JA, Bhan A.
International Journal of Tuberculosis and Lung Diseases 2011; 15(12):1563.

Read publication

Killer-cell immunoglobulin-like receptor genotyping and HLA killer-cell immunoglobulin-like receptor-ligand identification by real-time polymerase chain reaction.
Hong HA, Loubser S, de Assis Rosa D, Naranbhai V, Carr W, Paximadis M, Lewis DA, Tiemessen CT, Gray C.
Tissue Antigens 2011; 78(3):185-194.

Read publication

Short communication decreased incidence of dual infections in South african subtype C-infected women compared to a cohort ten years earlier.
Woodman W, Mlisana K, Treurnicht F, Abrahams M-R, Thebus R, Abdool Karim S, Williamson C for the CAPRISA Acute Infection Study Team.
AIDS Research and Human Retrovituses 2011; 27(11): 1167-1172.

Read publication

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, Hogg E, Rooney J, Wu X, Hosseinipour MC, Lalloo U, Veloso VG, Some FF, Kumarasamy N, Padayatchi N, Santos BR, Reid S, Hakim J, Mohapi L, Mugyenyi P, Sanchez J, Lama JR, Pape JW, Sattler FR, Asmelash A, Moko E, Sawe F, Andersen J, Sanne I, for the AIDS Clinical Trials Group Study A5221.
New England Journal of Medicine 2011; 365(16):1482-1491.

Read publication

Co-enrollment in multiple HIV prevention trials — Experiences from the CAPRISA 004 Tenofovir gel trial.
Abdool Karim Q, Kharsany ABM, Naidoo K, Yende N, Gengiah T, Omar Z, Arulappan N, Mlisana KP, Abdool Karim SS.
Contemporary Clinical Trials 2011; 32(3):333-338.

Read publication

The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4 T Cell Decline and High Viral Load during Acute Infection.
Gray ES, Madiga MC, Hermanus T, Moore PL, Wibmer CK, Tumba NL, Werner L, Mlisana K, Sibeko S, Williamson C, Abdool Karim SS, Morris L and the CAPRISA 002 Study Team.
Journal of Virology 2011; 85(10): 4828-4840.

Read publication

Time for gender mainstreaming in editorial policies.
Heidari S, Eckert MJ, Kippax S, Abdool Karim Q, Sow PS, Wainberg MA.
Journal of the International AIDS Society 2011; 14(1):11.

Read publication

Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function.
Naranbhai V, Bartman P, Ndlovu D, Ramkalawon P, Ndung'u T, Wilson D, Altfeld M, Carr WH.
Journal of Immunological Methods 2011; 366(1-2):28-35.

Read publication

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial.
Abdool Karim Q, Kharsany ABM, Frohlich JA, Baxter C, Yende N, Mansoor LE, Mlisana KP, Maarschalk S, Arulappan N, Grobler A, Sibeko S, Omar Z, Gengiah TN, Mlotshwa M, Samsunder N, Abdool Karim SS.
Trials 2011; 12:67. doi: 10.1186/1745-6215-12-67.

Read publication

Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa.
Abdool Karim Q, Kharsany ABM, Frohlich JA, Werner L, Mashego M, Mlotshwa M, Madlala BT, Ntombela F, Abdool Karim SS.
International Journal of Epidemiology 2011; 40(4):922-930.

Read publication

Interventions tomodify sexual risk behaviours for preventing HIV in homeless youth.
Naranbhai V, Abdool Karim Q,Meyer-Weitz A.
Cochrane Database of Systematic Reviews 2011; 19(1):CD007501. doi: 10.1002/14651858.CD007501.pub2.

Read publication

Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
Singh R, Gaiha G, Werner L, McKim K, Mlisana K, Luban J, Walker BD, Abdool Karim SS, Brass AL, Ndung'u T.
Journal of Virology 2011; 85(1):208-216.

Read publication

Archives

We use cookies to make your experience with us better. By continuing to use our website, you are agreeing to our use of cookies. To find out more see our privacy policy.

Close